Vernalis PLC Share News (VER)
VER Share
VER Share
VER Share
VER Share
VER
VER Share
VER Broker
VER Directors
VER Financial
VER
VER Short
VERTue, 02nd Oct 2018 15:56
LONDON (Alliance News) - Vernalis PLC on Tuesday said its acquisition by Ligand Holdings UK has been approved by shareholders.
The pharmaceutical company's shareholders passed the deal, in which Ligand will pay GBP32.7 million, or 6.2 pence per Vernalis share, with 95% of votes cast in favour.
Ligand is to fund the acquisition, which is being effected by means of a court-sanctioned scheme of arrangement, through existing cash reserves.
Shares in Vernalis were untraded at 6.12p on Tuesday.
Seneca Global Adds Aberdeen New Thai Director Gilding To Board
Read moreLONDON (Alliance News) - Shares in Vernalis PLC were temporarily suspended from trading on AIM on Wednesday as requested by the company pending an announcement.Last week, the pharmaceutical
Read moreWednesday 26 SeptemberIMIMobileHornbyNCC GroupPZ CussonsGateley 27
Read moreLONDON (Alliance News) - Pharmaceutical firm Vernalis PLC on Thursday said Ian Gilham is leaving his role as a non-executive director.Chairman Peter Fellner said: "We would like to Ian
Read more
(Sharecast News) - AIM-listed Vernalis has agreed to be bought by Ligand UK, a subsidiary of California-based Ligand Pharmaceuticals, for 6.2p per share in cash, valuing the company at around £32.67m.
Read moreLONDON (Alliance News) - Pharmaceutical company Vernalis PLC said Thursday that it reached an agreement to be taken over by Ligand Holdings UK Ltd.Ligand, a unit of US-listed company Ligand
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut
Read moreLONDON (Alliance News) - Pharmaceutical firm Vernalis PLC said Wednesday its interim loss widened sharply amid significant impairments following a restructuring, as it to a to
Read moreThursday 22 March HalmaTrading Statement CarnivalQ1 Results (at 1400 Group Year Year
Read moreLONDON (Alliance News) - Pharmaceutical firm Vernalis PLC said Thursday the company is up for sale, and it is also to begin winding down US operations.Vernalis said in
Read more(ShareCast News) - Vernalis and Tris Pharma said the US Food and Drug Administration (FDA) has accepted the CCP-08 New Drug Application (NDA) for full review. This triggered a milestone payment from AIM-quoted Vernalis to Tris. The FDA had set a Prescription Drug User Fee Act (PDUFA) target date
Read more
